-
Fast-Tracking the Diagnosis for Tough-to-Detect Autoimmune Conditions
What We Do at DiagnoDash?
- For Medical Professionals
- For Patients
-
Advanced AI
AssistanceDiagnoDash is dedicated to developing AI-driven tools to aid in the early detection of rare autoimmune diseases, enhancing the diagnostic process for medical professionals.
-
Data-Driven
PrecisionBy leveraging extensive datasets and sophisticated algorithms, our AI tools provide a high level of accuracy and detail, facilitating precise diagnoses.
-
Diagnostic
Navigation SupportDiagnoDash offers essential resources to medical professionals, guiding them through the complexities of diagnosing autoimmune conditions.
-
Empowering with
InformationDiagnoDash provides patients with comprehensive information about their conditions, including details on treatment options and symptom management.
-
Enhancing Patient
UnderstandingOur platform ensures that patients have access to the latest and most reliable information about their autoimmune condition, empowering them to be active participants in their healthcare.
-
Resource
AccessibilityDiagnoDash connects patients with various resources, from medical care to community support, to aid in their treatment and recovery process.
Impact of Autoimmune Disease
- Over 80 types of autoimmune conditions, affecting millions globally.
- Many of these, particularly the rarer forms, are notoriously difficult to diagnose due to their subtle and often overlapping symptoms.
- This diagnostic ambiguity not only complicates patient care but also contributes to the global burden of autoimmune diseases, affecting an estimated 4-7% of the world population.
Challenges with Diagnosis
-
01
Overlapping Symptoms
Many autoimmune diseases share similar symptoms with each other and with other non-autoimmune conditions, making it difficult to pinpoint a specific diagnosis.
-
02
Subtle Early Signs
Early symptoms of autoimmune diseases are often subtle and easily overlooked, delaying the recognition and diagnosis of the condition.
-
03
Complex Testing
Diagnosing autoimmune diseases often requires a combination of complex tests, including blood tests for specific autoantibodies and imaging studies, which can be time-consuming and require specialized interpretation.
-
04
Variability in Disease Presentation
The same autoimmune disease can present differently in different individuals, adding to the diagnostic complexity.
-
05
Lack of Awareness
Both in patients and sometimes in healthcare providers, there can be a lack of awareness or familiarity with less common autoimmune diseases, leading to misdiagnosis or delayed diagnosis.
-
06
Slow Disease Progression
Some autoimmune diseases progress slowly, making it challenging to detect significant changes over time that would prompt a diagnosis.
-
07
Absence of Definitive Tests
For many autoimmune diseases, there is no single diagnostic test that can definitively confirm the disease, often requiring a combination of clinical assessment and multiple tests for a conclusive diagnosis.
Benefits of Early Diagnosis
-
Enhanced Treatment Effectiveness
Early detection leads to more effective treatment, potentially slowing disease progression.
-
Prevention of Organ Damage
Timely intervention can prevent or minimize damage to organs affected by autoimmune diseases.
-
Symptom Severity Reduction
Early treatment can reduce the severity of symptoms, improving daily functioning.
-
Improved Quality of Life
Patients are likely to experience a better quality of life with early management of the disease.
-
Economic and Social Impact Mitigation
Early diagnosis helps patients maintain their social and work activities, reducing the economic burden.
-
Less Aggressive Treatment Required
Detecting diseases early often means less aggressive treatments are needed, minimizing side effects and complications.
-
Long-Term Health Outcomes
Early diagnosis and treatment lead to better long-term health and management of the disease.
Conditions We Support
In the next six months, DiagnoDash aims to significantly expedite the diagnosis of key autoimmune conditions. Leveraging the expertise of medical professionals, comprehensive data collection, and dedicated research, we're focusing on a targeted list of diseases for faster, more accurate diagnostic processes.
Causes dry eyes and mouth; affects 0.1-0.6% of the population. Diagnosis can take several years due to non-specific symptoms.
Affects various body systems; prevalence is about 20-150 cases per 100,000 people. Diagnosis can take years due to diverse symptoms.
Affects the digestive system; prevalence is about 1% globally. Diagnosis can take years due to non-specific gastrointestinal symptoms
Affects the central nervous system; about 90 cases per 100,000 people. Diagnosis may take months to years due to varied symptoms.
Causes joint inflammation; affects about 0.5-1% of the global population. Diagnosis can take weeks to years, depending on symptom severity.
Skin condition; affects 2-3% of the global population. Diagnosis is often quicker, but can be confused with other skin conditions.
A type of inflammatory bowel disease; affects about 322 per 100,000 adults. Diagnosis can take months to years due to similar symptoms with other gastrointestinal diseases.
Another type of inflammatory bowel disease; prevalence is about 249 per 100,000 adults. Similar to Crohn's, diagnosis can take months to years
Affects the thyroid gland; prevalence is about 1-2% of the population. Diagnosis can take years due to gradual onset of symptoms
Another thyroid-related autoimmune disease; affects about 0.5% of the population. Diagnosis can vary from months to a few years.
Affects neuromuscular junction; prevalence is about 20 cases per 100,000 people. Diagnosis can take months to years due to the variability of symptoms.
Affects the spine; prevalence is about 0.1-0.5% of the adult population. Diagnosis can take several years due to slow disease progression.
Inflammation of blood vessels; specific prevalence varies by type. Diagnosis can be challenging and time-consuming due to non-specific symptoms.
Causes skin hardening; about 50-300 cases per million individuals. Diagnosis can take years due to gradual symptom onset
Affects adrenal glands; about 110-144 cases per million. Diagnosis can take years due to non-specific symptoms like fatigue.
Causes vitamin B12 deficiency; affects about 0.1% of the general population. Diagnosis can take years due to subtle symptoms.
A liver disease; affects about 40 per 100,000 people. Diagnosis can take years as early stages are often asymptomatic.
Affects the liver; prevalence is about 10-20 cases per 100,000 people. Diagnosis can be delayed due to non-specific symptoms.
Mimics pancreatic cancer; affects about 4.6 cases per 100,000 people. Diagnosis can take months to years due to similarities with other pancreatic conditions.
Causes inflammation in the arteries of the head, especially the temples; affects about 200 per million people over 50 years of age annually. Diagnosis can be challenging due to its nonspecific initial symptoms like headaches and jaw pain and can take months to years.
DiagnoDash AI Model
Building an AI model to assist and expedite the diagnosis of diseases, especially in the complex field of autoimmune disorders, requires a diverse and comprehensive set of datasets. These datasets should encompass various aspects of patient health and disease characteristics.
-
Clinical Data
Clinical Data
Radiological images such as X-rays, MRIs, CT scans, and ultrasound images, particularly useful for conditions like rheumatoid arthritis, multiple sclerosis, or any disease with observable physiological changes.
-
Laboratory Test Results
Laboratory Test Results
Data from blood tests, including autoantibody profiles, inflammatory markers, and other relevant blood chemistry parameters.
-
Imaging Data
Imaging Data
Radiological images such as X-rays, MRIs, CT scans, and ultrasound images, particularly useful for conditions like rheumatoid arthritis, multiple sclerosis, or any disease with observable physiological changes.
-
Genomic Data
Genomic Data
Genetic information can be crucial, especially considering the hereditary aspects of many autoimmune diseases.
-
Biopsy Data
Biopsy Data
Histopathological data from tissue biopsies, which are often definitive in diagnosing conditions like vasculitis, dermatomyositis, or scleroderma.
-
Epidemiological Data
Epidemiological Data
Population-level data that can provide insights into disease prevalence, demographic patterns, and risk factors.
-
Treatment Response Data
Treatment Response Data
Information on how patients have responded to various treatments, which can help in predicting the most effective therapies for new patients.
-
Patient Reported Outcomes
Patient Reported Outcomes
Self-reported data on symptoms severity, quality of life, and functional status.
-
Environmental Exposure Data
Environmental Exposure Data
Information on patients' exposure to potential environmental triggers, which can be relevant in autoimmune diseases.
-
Pharmacological Data
Pharmacological Data
Data on medication usage and its impacts, which is essential for understanding treatment efficacy and adverse effects.
-
Wearable Device Data
Wearable Device Data
If available, data from wearable health devices can provide continuous monitoring information, like heart rate or activity levels, which can be valuable for certain conditions.
-
Socioeconomic & Lifestyle Data
Socioeconomic & Lifestyle Data
These factors can influence disease onset and progression, and their inclusion can enrich the predictive power of AI models.
Launch Plan & Product Roadmap
Work in progress, will be updated soon
Interested to Work with Us
At DiagnoDash, we are on a mission to revolutionize the field of autoimmune disease diagnosis through innovative AI-driven solutions. Our journey is fueled by collaboration, expertise, and shared vision. If you are as passionate as we are about transforming healthcare and have something unique to contribute, we would love to hear from you.
Opportunities for Collaboration
- Investors
- Data Sharing
- Expert Advice
- Partnerships
If you are looking to invest in cutting-edge healthcare technology, DiagnoDash offers a unique opportunity. We are at the forefront of AI in healthcare, making significant strides in diagnosing autoimmune diseases.
Researchers or institutions with relevant data sets – your contribution can be pivotal in enhancing the accuracy and efficiency of our AI models.
Are you an expert in healthcare, AI, or related fields? Your insights and advice could be invaluable in refining our approach and methodologies.
- We are open to forming partnerships with healthcare providers, research institutions, and technology companies. Together, we can create synergies that drive forward our shared goal of improved healthcare outcomes.
- Your expertise, resources, and insights could play a crucial role in the success of DiagnoDash. To explore how we can work together, please reach out to our team by filling out the form below. Your input could be the key to unlocking new possibilities in healthcare diagnostics.
- We look forward to the potential of working together to make a meaningful impact in healthcare.
Get in touch with us